Enzyme Drives Cognitive Decline in Mice, Provides New Target for Alzheimer’s

UC San Diego researchers identify the PKC? enzyme as a promising therapeutic target in Alzheimer’s disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice.

Click here to view original post